Impact of endothelin-1 on microcirculatory disturbance after partial hepatectomy under ischemia/reperfusion in thioacetamide-induced cirrhotic rats

Journal of Surgical Research

Volumn 111, Issue 1, 2003, Pages 100-108

  Tsuchiya, Yasuo ^a   Suzuki, Shohachi ^a   Inaba, Keisuke ^a   Sakaguchi, Takanori ^a   Baba, Satoshi ^a   Miwa, Mitsuharu ^b   Konno, Hiroyuki ^a   Nakamura, Satoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

Endothelin 1; Hepatectomy; Ischemia; Liver; Liver cirrhosis; Microcirculation; Pringle's maneuver; Reperfusion injury; Time resolved spectroscopy

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; SULFUR DIOXIDE; TAK 044; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LIVER; LIVER CIRRHOSIS; LIVER CONGESTION; LIVER ISCHEMIA; MALE; MICROANGIOPATHY; MICROCIRCULATION; NONHUMAN; OXYGEN SATURATION; PARTIAL HEPATECTOMY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; REPERFUSION; SPECTROSCOPY; SURVIVAL RATE; TIME;

EID: 0038046989     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00078-7     Document Type: Article

References (48)

1. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann. Surg. 211:1990;277.
2. Pringle J.H. Notes on the arrest of hepatic hemorrhage due to trauma. Ann. Surg. 48:1908;541.
3. Belghiti J., Noun R., Malafosse R., Jagot P., Sauvanet A., Pierangeli F., Marty J., Farges O. Continuous versus intermittent portal triad clamping for liver resection. Ann. Surg. 229:1999;369.
4. Huguet C., Gavelli A., Addario C.P., Bona S., Harb J., Joseph J.M., Jobard J., Gramaglia M., Lasserre M. Liver ischemia for hepatic resection Where is the limit? Surgery. 111:1992;251.
5. Wakashiro S., Shimahara Y., Ikai I., Tokunaga Y., Ozaki N., Tanaka A., Morimoto T., Ozawa K. Influence of hypoxia on mitochondrial function and energy status in CCl4-induced cirrhotic rat liver. Res. Exp. Med. 189:1989;153.
6. van Wagensveld B.A., van Gulik T.M., Gelderblom H.C., Scheepers J.J.G., Bosma A., Endert E., Gouma D.J. Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs. Ann. Surg. 229:1999;376.
7. Belghiti J., Noun R., Zante E., Ballet P., Sauvanet A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A control study. Ann. Surg. 224:1996;155.
8. Camargo C.A. Jr, Madden J.F., Gao W., Selvan R.S., Clavien P.A. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology. 26:1997;1513.
9. Kukan M., Vajdova K., Horecky J., Nagyova A., Mehendale H.M., Trnovec T. Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia-reperfusion injury of rat liver. Hepatology. 26:1997;1250.
10. Lentsch A.B., Yoshidome H., Cheadle W.G., Miller F.N., Edwards M.J. Chemokine involvement in hepatic ischemia/reperfusion injury in mice Roles for macrophage inflammatory protein-2 and Kupffer cells . Hepatology. 27:1998;507.
11. Muller A., Machnik F., Zimmermann T., Schubert H. Thioacetamide-induced cirrhosis-like liver lesions in rats. Usefulness and reliability of this animal model. Exp. Pathol. 34:1988;229.
12. Dashti H., Jeppsson B., Hagerstrand I., Hultberg B., Srinvas U., Abdulla M., Bengmark S. Thioacetamide- and carbon tetrachloride-induced liver cirrhosis. Eur. Surg. Res. 21:1989;83.
13. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411.
14. Rockey D.C., Fouassier L., Chung J.J., Carayon A., Vallee P., Rey C., Housset C. Cellular localization of endothelin-1 and increased production in liver injury in the rat Potential for autocrine and paracrine effects on stellate cells . Hepatology. 27:1998;472.
15. Pinzani M., Milani S., De Franco R., Grappone C., Caligiuri A., Gentilini A., Tosti-Guerra C., Maggi M., Failli P., Ruocco C., Gentilini P. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology. 110:1996;534.
16. Okumura S., Takei Y., Kawano S., Nagano K., Masuda E., Goto M., Tsuji S., Michida T., Chen S.S., Kashiwagi T., Fusamoto H., Kamada T., Sato N. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology. 19:1994;155.
17. Warner T.D., Allcock G.H., Mickley E.J., Corder R., Vane J.R. Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. J. Cardiovasc. Pharmacol. 22:(Suppl. 8):1993;S117.
18. Housset C., Rockey D.C., Bissell D.M. Endothelin receptors in rat liver Lipocytes as a contractile target for endothelin-1 . Proc. Natl. Acad. Sci. USA. 90:1993;9266.
19. Asbert M., Gines A., Gines P., Jimenez W., Claria J., Salo J., Arroyo V., Rivera F., Rodes J. Circulating levels of endothelin in cirrhosis. Gastroenterology. 104:1993;1485.
20. Mathew J., Geerts A., Burt A.D. Pathobiology of hepatic stellate cells. Hepatogastroenterology. 43:1996;72.
21. Rockey D.C., Weisiger R.A. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver Implications for regulation of portal pressure and resistance . Hepatology. 24:1996;233.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248.
23. Suzuki N., Matsumoto H., Kitada C., Masaki T., Fujino M. A sensitive sandwich-enzyme immunoassay for human endothelin. J. Immunol. Methods. 118:1989;245.
24. Miwa M., Ueda Y., Chance B. Development of time resolved spectroscopy system for quantitative non-invasive tissue measurement. SPIE. 2389:1995;142.
25. Mitsuoka H., Suzuki S., Sakaguchi T., Baba S., Miwa M., Konno H., Nakamura S. Contribution of endothelin-1 to microcirculatory impairment in total hepatic ischemia and reperfusion injury. Transplantation. 67:1999;514.
26. So S.K., Monge H., Esquivel C.O. Major hepatic resection without blood transfusion Experience with total vascular exclusion . J. Gastroenterol. Hepatol. 14:(Suppl.):1999;S28.
27. Yamaoka Y., Ozawa K., Kumada K., Shimahara Y., Tanaka K., Mori K., Takayasu T., Okamoto R., Kobayashi N., Konishi Y., Egawa H. Total vascular exclusion for hepatic resection in cirrhotic patients. Application of venovenous bypass. Arch. Surg. 127:1992;276.
28. Nakamura S., Nishiyama R., Serizawa A., Yokoi Y., Suzuki S., Konno H., Baba S., Muro H. Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation. 59:1995;679.
29. Uhlmann D., Witzigmann H., Senninger N., Hauss J., Spiegel H.U. Protective role of an endothelin-coverting enzyme inhibitor (FR901533) in hepatic ischemia/reperfusion injury. Microvasc. Res. 62:2001;43.
30. Fukunaga K., Takada Y., Taniguchi H., Mei G., Seino K., Yuzawa K., Otsuka M., Todoroki T., Goto K., Fukao K. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors. Transplantation. 67:1999;328.
31. Sunose Y., Ohwada S., Takeyoshi I., Matsumoto K., Tatsumi H., Tomizawa N., Kawate S., Morishita Y. Effects of endothelin receptor antagonist TAK-044 on small bowel autograft from a controlled non-heart-beating donor model. Surgery. 130:2001;819.
32. B receptors in human cirrhosis Relationship with hepatic hemodynamics . J. Vasc. Res. 35:1998;186.
33. de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T.D., Vane J.R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA. 85:1998;9797.
34. Kitayama Y., Yamanaka N., Okamoto E., Kusumoto K., Fujiwara A., Watanabe T. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the cirrhotic rat liver. Hepatol. Res. 13:1998;1.
35. Gandhi C.R., Nemoto E.M., Watkins S.C., Subbotin V.M. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats. Liver. 18:1998;39.
36. Dhar D.K., Yamanoi A., Ohmori H., Nakashima Y., Yamamoto A., Osama N.E.A., Kubota H., Kohno H., Nagasue N. Modulation of endothelin and nitric oxide A rational approach to improve canine hepatic microcirculation . Hepatology. 28:1998;782.
37. Elliot A.J., Vo L.T., Grossman V.L., Bhathal P.S., Grossman H.J. Endothelin-induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats. J. Gastroenterol. Hepatol. 12:1997;314.
38. Reichen J., Gerbes A.L., Steiner M.J., Sagesser H., Clozel M. The effect of endothelin and its antagonist bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver. J. Hepatol. 28:1998;1020.
39. Kuddus R.H., Nalesnik M.A., Subbotin V.M., Rao A.S., Gandhi C.R. Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes. An important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J. Hepatol. 33:2000;725.
40. Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J. Hepatobiliary Pancreat. Surg. 5:1998;402.
41. Toledo-Pereyra L.H., Suzuki S. Neutrophils, cytokines, and adhesion molecules in hepatic ischemia and reperfusion injury. J. Am. Coll. Surg. 179:1994;758.
42. Serracino-Inglott F., Habib N.A., Mathie R.T. Hepatic ischemia-reperfusion injury. Am. J. Surg. 181:2001;160.
43. Suzuki S., Nakamura S., Sakaguchi T., Ochiai T., Konno H., Baba S., Baba S. Alteration of reticuloendothelial phagocytic function and tumor necrosis factor-α production after total hepatic ischemia. Transplantation. 64:1997;821.
44. 4-induced liver cirrhosis. Res. Exp. Med. 190:1990;173.
45. Nakatani Y., Fukui H., Kitano H., Nagamoto I., Tsujimoto T., Kuriyama S., Kikuchi E., Hoppou K., Tsuji T. Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis. Liver. 21:2001;64.
46. Ruetten H., Thiemermann C.H. Endothelin-1 stimulates the biosynthesis of tumor necrosis factor in macrophages ET-receptors, signal transduction and inhibition by dexamethasone . J. Physiol. Pharmacol. 48:1997;675.
47. Suzuki S., Serizawa A., Sakaguchi T., Tsuchiya Y., Kojima Y., Okamoto K., Kurachi K., Konno H., Fujise Y., Baba S., Nakamura S. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. Transplantation. 69:2000;2267.
48. Farre A.L., Riesco A., Espinosa G., Digiuni E., Cernadas M.R., Alvarez V., Monton M., Rivas F., Gallego M.J., Egido J., Casado S., Caramelo C. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation. 88:1993;1166.